High- and Low-risk Actinic Keratosis Referrals to Secondary Care

Active, not recruitingOBSERVATIONAL
Enrollment

3,379

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

December 1, 2025

Conditions
Actinic Keratoses
Trial Locations (1)

Unknown

Ellen Oyen, Maastricht

All Listed Sponsors
collaborator

Tergooi Hospital

OTHER

lead

Maastricht University Medical Center

OTHER